Cogniant logo — Accelerating patient-led neuroscience research using digital...

Cogniant

Accelerating patient-led neuroscience research using digital biomarkers

Founded 2015 Singapore Singapore 7 employees Pre-Seed Total: $120.00K AI, Health Care +3

General Information

Company Name Cogniant
Founded Year 2015
Location Singapore Singapore
Employees 7
Industries AI, Health Care, Health and Wellness +2
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Cogniant. To contact Cogniant, visit cogniant.co.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Cogniant

Cogniant is dedicated to accelerating patient-led neuroscience research using digital biomarkers. The company's slogan, "Accelerating patient-led neuroscience research using digital biomarkers," encapsulates its focus on enabling expansive digital phenotyping, clinical state predictions, and outcomes measurement. Based in Singapore, Cogniant operates in an industry that is at the forefront of leveraging technology to advance healthcare. As of now, no specific details about its founding date, industries targeted, or past investments are available. However, given the increasing importance of digital health and neuroscience research, Cogniant holds promise as a potential target for venture capital investment. Its novel approach to utilizing digital biomarkers and empowering patients in the realm of neuroscience research makes it an intriguing prospect for investors seeking opportunities at the intersection of healthcare and technology.

Taxonomy: Neuroscience, Digital Biomarkers, Remote Monitoring, Clinical Trials, Mental Health, Digital Phenotyping, Deep Learning, Real World Evidence, Digital Medicine, Data Collection, Virtual Clinical Trials

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $120.00K 1
Techstars
10 Jan 2021

Cogniant Alternatives & Competitors

Cogniant vs

A clinical stage biotech informed by patient experience. Tackling unmet needs in neuroscience & ment...

Post-IPO Equity
11 employees
Health Care, Health and Wellness
Cogniant vs

PatchAi® is a virtual assistant for patients in clinical trials that uses conversational patient-rep...

Seed
2 employees
AI, Analytics
Cogniant vs
Ancora.ai
Ancora.ai Switzerland

Ancora.ai is a patient-first, digital clinical trial navigation tool connecting cancer patients to c...

Grant
9 employees
AI, Big Data

FAQ About Cogniant

Accelerating patient-led neuroscience research using digital biomarkers
Cogniant was founded in 2015.
Cogniant is headquartered in Singapore.
Cogniant operates in AI, Health Care, Health and Wellness, Insurtech and Machine Learning. Its work centres on Neuroscience, Digital Biomarkers, Remote Monitoring and Clinical Trials.
Cogniant has approximately 7 employees.
Cogniant has completed 1 funding round, raising a total of $120.00K. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Cogniant include Emyria (ASX:EMD), Patchai, an Alira Health Company, Ancora.ai, Holmusk, Heartbeat Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cogniant and Emyria (ASX:EMD) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cogniant, https://bouncewatch.com/company/cogniant, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes